Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
SURI
US82889N6242
SURI ETF · Simplify Propel Opportunities ETF
The SURI Exchange Traded Fund (ETF) is provided by Simplify. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
Last update Today at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofMultiple Trends1M perf.-1.86%
Last price
$17.00
1M perf.
+5.38%
1M flows
-€1.6M
AuM
€67M
E/R
2.82%
Rating
Not rated
ESG Consensus®
SURI
$17.00
Performance & flows
December 11, 2025 → March 11, 2026
Create a free account to view the flows graph
SURI
$17.44
+0.63%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | +5.38% | +0.63% | +27.13% | +26.95% | N/A | +1.04% | +3.81% | +3.81% | |
| Flows |
Key fund info
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
3/11/2026
$17.44
1D NAV change
+0.58%
Dividend policy
No. of holdings
27
Inception date
2/7/2023
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Investment Company
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
The Simplify Propel Opportunities ETF (the “Fund”) seeks to provide long-term growth of capital.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseAdvertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +0.63% | +27.13% | +26.95% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
82.57%
Canada
4.86%
Switzerland
3.46%
Unavailable
9.11%
Sectors
Health Care
37.94%
Energy
33.86%
Communication services
1.05%
Unavailable
27.15%
Diversification
Total weight of top 15 holdings out of 27
Top 15 holdings
Data as of January 31, 2026
PLAINS GP HOLDINGS
ACHIEVE LIFE SCIENCES
PHATHOM PHARMACEUTICALS INC
VIRIDIAN THERAPEUTICS INC
MILESTONE PHARMACEUTICALS INC
DELCATH SYSTEMS
CH1242303498
ABEONA THERAPEUTICS
Create a free account to view top holdings
US46124U1079
CELLDEX THERAPEUTICS
US0044681874
COMPASS PATHWAYS ADR
US5019761049
US6402683063
4D MOLECULAR THERAPEUTICS INC
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Simplify
Simplify ID Card
Number of funds
40
Total AuM
€11.3B
Expense ratio range
0.15% - 2.82%
Average expense ratio
0.6785%
Top 5 funds by Simplify
| AuM | ||
|---|---|---|
SBIL | Simplify Government Money Market ETF | €4.09B |
MTBA | Simplify MBS ETF | €1.49B |
CTA | Simplify Managed Futures Strategy ETF | €1.19B |
TUA | Simplify Short Term Treasury Futures Strategy ETF | €574M |
SVOL | Simplify Volatility Premium ETF | €514M |
Frequently asked questions about SURI
What does Simplify Propel Opportunities ETF, SURI, invest in?
SURI is a Active ETF. This ETF provides exposure to Mixed Ratings Aggregate Equities and Bonds.
What is the Total Expense ratio (TER) of SURI?
SURI carries a total expense ratio (TER) of 2.82%, indicating the annual cost for holding the fund.
When was SURI launched?
SURI was introduced to the market on February 7, 2023. It trades on United States
Who is the ETF issuer of SURI?
Simplify Propel Opportunities ETF, SURI, is provided by Simplify. Learn more about Simplify here.
What is the current assets under management (AUM) of SURI?
SURI oversees €67M in assets as of March 11, 2026.
How has SURI performed lately?
Based on data from March 11, 2026, SURI returned 5.38% over the past month, 0.63% over the last three months and 3.81% year-to-date.
What are the latest inflows or outflows for SURI?
As of March 11, 2026, SURI recorded net flows of -€1.6M over the last month and -€1.1M year-to-date.
Does SURI distribute dividends?
SURI follows a distributing dividend policy, meaning it pays out income to investors. As of March 11, 2026, its 12-month trailing yield was 15.60%.
What are the main country or region exposures of SURI?
As of January 31, 2026, SURI has significant geographic allocations in USA, Canada and Switzerland.
In which sector or theme does SURI invest in?
As of January 31, 2026, SURI focuses largely on Health Care, Energy and Communication services.
How many securities does SURI hold and how diversified is it?
As of January 31, 2026, SURI holds 27 positions in its portfolio, with 82.42% of assets concentrated in its top 15 holdings.
What are the main positions in SURI?
As of January 31, 2026, SURI top three holdings include PLAINS GP HOLDINGS, ACHIEVE LIFE SCIENCES and PHATHOM PHARMACEUTICALS INC.
What is the base currency of SURI?
The base currency of SURI is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
